Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Biochemical changes in fibromyalgia]

W Samborski1, T Stratz, T Schochat

  • 1Hochrheininstitut für Rehabilitationsforschung, Bad Säckingen.

Zeitschrift Fur Rheumatologie
|May 1, 1996
PubMed
Summary

Fibromyalgia patients show altered neurotransmitter levels, with decreased serotonin and somatomedin C, and increased prolactin. These biochemical markers may aid in confirming fibromyalgia diagnosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The classification of fibromyalgia syndrome.

Rheumatology international·2007
Same author

[Subgroups of fibromyalgia].

Schmerz (Berlin, Germany)·2007
Same author

[5-HT3 receptor antagonist als analgetics in rheumatic diseases].

Zeitschrift fur Rheumatologie·2006
Same author

[Controlled trials on the efficacy of occupational therapy with elderly. Part I: Research question, search strategy and methodological quality of trials].

Zeitschrift fur Gerontologie und Geriatrie·2004
Same author

[Controlled trials on the efficacy of occupational therapy with elderly. Part II: Evidence for prioritized diseases and disabilities].

Zeitschrift fur Gerontologie und Geriatrie·2004
Same author

Expression of 5-HT3A receptors in cells of the immune system.

Scandinavian journal of rheumatology. Supplement·2004

Area of Science:

  • Biochemistry
  • Neuroscience
  • Rheumatology

Context:

  • Fibromyalgia is a complex chronic pain disorder.
  • Neurotransmitter imbalances are implicated in fibromyalgia pathophysiology.
  • Objective diagnostic markers for fibromyalgia are needed.

Purpose:

  • To investigate specific biochemical markers for fibromyalgia diagnosis.
  • To compare neurotransmitter levels in fibromyalgia patients versus healthy controls.

Summary:

  • Patients meeting ACR criteria for fibromyalgia (n=60) and controls (n=20) had serotonin, somatomedin C, calcitonin, prostaglandin E2, oxytocin, ACTH, substance P, TSH, and prolactin levels measured.
  • Fibromyalgia patients exhibited significantly lower serotonin, somatomedin C, calcitonin, and prostaglandin E2 levels.
  • Elevated prolactin levels were observed in fibromyalgia patients, while ACTH, substance P, and TSH showed no significant differences.

Impact:

  • Findings suggest that specific biochemical parameters, including neurotransmitter levels, could potentially confirm fibromyalgia diagnosis.
  • Further research is warranted to establish the diagnostic utility of these biochemical findings in clinical practice.

Related Experiment Videos